Correta Trial (Corticosteroid Reduction with Tacrolimus): prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus [Prograf] and mycophenolate mofetil [Cellcept] immunosuppression regimen kidney transplant recipients,

Trial Profile

Correta Trial (Corticosteroid Reduction with Tacrolimus): prospective Brazilian multicenter, randomized trial of early corticosteroid reduction versus regular corticosteroid dosage maintenance on a tacrolimus [Prograf] and mycophenolate mofetil [Cellcept] immunosuppression regimen kidney transplant recipients,

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2010

At a glance

  • Drugs Mycophenolate mofetil; Prednisone; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Acronyms CORRETA
  • Most Recent Events

    • 21 Jan 2010 Results published in Clinical Transplantation.
    • 14 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top